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Summary
Diagnosis Related Groups (DRGs) are currently being in-
troduced on a national scale as a prospective reimburse-
ment scheme in Swiss in-patient hospital care, replacing
any remaining retrospective day-rate arrangements. DRGs
are expected to promote transparency and efficiency while
helping to contain health care costs. The governmental de-
cision to introduce DRGs has caused considerable contro-
versy among different stakeholders, due to diverging ap-
praisals of what will happen when DRGs are introduced as
an economic management tool in Switzerland. The contro-
versial discourse on DRGs is particularly interesting from
an ethical point of view, since all arguments inevitably
contain ethical considerations. In this paper we summarise
the results of our exploratory ethical studies that have led
to a larger research project funded by the Swiss National
Science Foundation: “Impact of Diagnosis-Related Groups
(DRGs) on patient care and professional practice” (IDoC).
In section 1: ‘Developing an understanding of the ethical
issues at stake’ we briefly explain how DRGs work, what
the intended effects are, what the public is concerned about
and what the scientific research tells us so far. In section 2:
‘Developing an ethical framework for research on DRGs in
Switzerland’ we summarise the ethical issues and explain
the ethical framework we will use in order to perform re-
search on the complex issue of DRGs in Switzerland. Only
once a profound understanding of the challenges exists can
research on the ethical implications of DRGs be successful.
Key words: DRG; prospective payment system; ethics;
research
Introduction
Diagnosis Related Groups (DRGs) are currently being in-
troduced on a national scale as a prospective reimburse-
ment scheme in Swiss in-patient hospital care, thereby re-
placing any remaining retrospective day-rate arrangements.
DRGs are expected to promote transparency and efficiency
while helping to contain health care costs. At the same
time, compromised quality of patient care, less equitable
access to health care services, shifting delivery of health
care to inadequately prepared institutions such as nursing
homes, and decreasing job satisfaction among nurses and
physicians are anticipated problems. The governmental de-
cision to introduce DRGs has caused considerable contro-
versy among different stakeholders, due to the diverging
appraisals of what will happen when DRGs are introduced
as an economic management tool throughout Switzerland.
The controversial discourse on DRGs is particularly inter-
esting from an ethical point of view, since all arguments in-
evitably contain ethical considerations. The expected posit-
ive or negative effects of DRGs touch on moral norms and
values such as the patient’s welfare, professional autonomy
or distributive justice in health care. This is the reason
why the Institute of Biomedical Ethics, at the University of
Zurich, has launched an interdisciplinary study on ethically
relevant effects of DRGs in Switzerland, entitled “Impact
of Diagnosis-Related Groups (DRGs) on patient care and
professional practice” (IDoC; SNF funded Sinergia-Pro-
ject. cf. http://www.ethik.uzh.ch/ibme/forschung/drg.html).
However, to date there are no sophisticated ethical tools
that would allow research on cost containment instruments.
Furthermore, the challenging issue of DRGs cannot be ad-
dressed by bioethicists alone, but depends on exchange
with other disciplines and perspectives. In preparation for
the IDoC study we therefore conducted a three-year long
exploratory study in order to (1.) develop an ethical un-
derstanding of the issues at stake and to (2.) design an
ethical framework for the research project. Our methods
for the development of the research project were varied;
among them, we conducted a literature review which in-
cluded publications on DRGs from the 1960s in the USA.
Furthermore we built up a national and international net-
work of experts from different disciplines, such as health
economics, law, nursing, public health research, medicine
and sociology. We conducted several empirical studies, in-
cluding pilot qualitative interview studies in Swiss hospit-
als (covering internal medicine, paediatrics, surgery, geriat-
rics) and qualitative interviews with stakeholders on DRGs
in Switzerland (http://www.research-projects.uzh.ch/
p12264.htm), as well as a small Delphi study in Switzer-
land in order to refine and confirm the results [1].
In this paper we will summarise the results of the explor-
atory studies that served as a basis for the current IDoC
project. In section 1: 'Developing an understanding for the
ethical issues at stake', we will briefly explain how DRGs
work, what the intended effects are, what the public is con-
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cerned about, and what the scientific research tells us so far.
In section 2: 'Developing an ethical framework for research
on DRGs in Switzerland', we will summarise the ethical is-
sues and explain the ethical frame that we will use in or-
der to perform research on the complex issue of DRGs in
Switzerland. Only once a profound understanding of the
challenges involved exists can research on the ethical im-
plications of DRGs be successful.
Developing an understanding of the
ethical issues at stake
How do DRGs work?
DRGs as a reimbursement system are a standardising sys-
tem (see for example http://www.fischer-zim.ch/artikel-
pdf/DRG-CH-Modellwahl-0404.pdf). Depending on the
main diagnosis, which is based on the International Stat-
istical Classification of Diseases and Related Health Prob-
lems (ICD-10), each patient case is assigned to a Major
Diagnostic Category (MDC; in German: Hauptdiagnose-
gruppe). For the calculation of the actual DRG, the MDC
is the most important factor. Other factors that are included
in the calculation are secondary diagnoses, procedures, age,
the degree of difficulty and others. The resulting DRG
is linked to a prospectively calculated average length of
stay (LOS) with a minimum and maximum limit. The cost
weight of the DRG is multiplied by the politically defined
base rate. The hospital can charge this amount for the treat-
ment of the relevant patient. A hospital can only have costs
under control if the actual LOS of its patients remains
around the average LOS, that is, above the minimum and
below the maximum LOS. DRGs thus encourage physi-
cians to focus on the main diagnosis, to run procedures as
efficiently as possible and to discharge the patient within
the average LOS in order to remain profitable.
The increasingly detailed documentation of diagnoses and
procedures, aimed at contributing to the transparency re-
garding costs and health services, can be used to facilitate
benchmarking and controlling and is expected to lead to
further competition between hospitals. This process is in-
tended to cut overcapacities.
In summary, the health economic tool “DRGs” is a stand-
ardising system that implements incentives with the ul-
timate aims of efficient procedures, cost-containment,
benchmarking, controlling, transparency, competition and
responsibility.
Why implement DRGs?
For an ethical analysis it is important to investigate the ex-
pected benefits of DRGs. What were the initial ideas lead-
ing to the development of DRGs in the 1960s and what are
the current positive aims that are connected with the imple-
mentation of DRGs in Switzerland?
The prospective payment system (PPS) “Diagnosis Related
Groups” has its roots in the USA. Facing excessively in-
creasing costs in health care, a new “incentive method of
reimbursement was to be studied” [2]. The traditional ret-
rospective payment system had led to several problems be-
cause of its inherent incentives, namely to keep patients
longer in hospital than necessary and to provide avoidable
tests and services (this system has been in use in some hos-
pitals in Switzerland up to the year 2011). The choice fell
on DRGs, which had been developed in the early 1960s
at Yale University in the context of quality control as a
tool for patient classification [3]. In 1983 DRGs were intro-
duced for the first time as the new reimbursement system
for Medicare patients in the USA [4]. The stated objectives
of the federal government were to standardise prices of ser-
vices and to control federal costs by providing incentives
for the hospitals and physicians to work more efficiently
and to use resources parsimoniously [2].
Subsequently DRGs have been implemented in different
versions in several other countries (such as Australia, Ger-
many, Scandinavia including Latvia, France, Ireland, Ro-
mania, Slovenia, Croatia, Spain, Turkey, Italy and others).
Several Asian countries are currently considering the im-
plementation of DRGs as well. In most countries the pro-
cess of implementation is relatively recent or even just
starting, and thus still fairly experimental.
Similarly to other countries the implementation of DRGs
in Germany in 2004 was motivated by the search for meas-
ures to contain health care costs. The German DRG system
(G-DRG) is currently the most complex and comprehens-
ive system worldwide.
After a detailed health economics assessment, which began
as early as 1985 the decision to develop a Swiss version
of DRGs was made in 2003 (http://www.swissdrg.org/de/
07_casemix_office/Entwicklungsprozess.asp?navid=10).
In 2006 the Swiss Government bought the G-DRG system
from the German DRG-institution, InEK gGmbH, includ-
ing all rights for further development and modification.
Subsequently, in 2007 the Swiss Parliament decided to
change the national health insurance law (KVG, Bundesge-
setz über die Krankenversicherung) in order to regulate
hospital reimbursement through prospectively calculated
Diagnosis Related Groups (http://www.admin.ch/ch/d/as/
2008/2049.pdf). From the beginning, an academic analysis
accompanied the process of introducing DRGs in Switzer-
land (e.g. [5, 6]; see also http://www.fischer-zim.ch/artikel-
pdf/DRG-CH-Modellwahl-0404.pdf).
In 2008 the non-profit incorporated company “SwissDRG
AG” (SwissDRG AG is a non-profit incorporated com-
pany. http://www.swissdrg.org) was founded with the aim
of developing and calculating the structure of tariffs for
DRGs in Switzerland. The administrative board includes
members from cantonal governments (Gesundheits-
direktoren), hospitals, medical associations and insurance
companies. As stipulated by “SwissDRG AG” the aim of
implementing DRGs in Switzerland is to improve trans-
parency and comparability of hospital costs, economic vi-
ability of the Swiss health care system, optimisation of
processes, cooperation among different disciplines and in-
stitutions, national planning of hospitals, efficiency and
standardisation of health care professionals’ work and pa-
tient care through optimised working procedures and high-
er competition of quality among the hospitals (ht-
tp://www.swissdrg.org/de/07_casemix_office/
Ziele.asp?navid=7).
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Anticipated problems in Germany and Switzerland
We will now turn to the tensions that accompanied the im-
plementation of DRGs by looking at the public perception
of DRGs and pointing towards selected scientific research
results. In terms of DRGs, Germany is an important ref-
erence point for Switzerland in many aspects. SwissDRGs
are based on G-DRGs which – like in Switzerland – serve
not only as an accounting system but also as a reimburse-
ment instrument for almost all in-patient health covered by
basic health insurance. Both health care systems have sim-
ilarities, and also the historical and cultural backgrounds
are partially comparable.
The implementation of DRGs provoked a wave of protest
among physicians in Germany [7, 8]. It triggered a fierce
debate between proponents of professional medical think-
ing on the one side and economic thinking on the other
side [9]. Speaking of “modern factories of medicine” one
physician pointed to what he perceived as the industrial-
isation of health care, with emotionless engineers func-
tioning only in terms of standardisation and profit, and he
evoked individuality and relationships as the essential ele-
ments of medicine [10]. According to another statement
core elements like medical competence and social skills
could be subordinated in an enterprise that was steered by
“controlling” [11]. In an open letter to the Federal Chan-
cellor, the “Workshop Group of Scientific Associations of
Germany” fought against what it saw as the imminent col-
lapse of academic medicine, caused by inappropriately de-
veloped structures for reimbursing education and training
under DRG conditions [12]. Students shared these concerns
about the new developments in medicine that seemed to
move away from a relationship-oriented health care [13].
In Switzerland the introduction of DRGs was also awaited
with some apprehension concerning possible negative con-
sequences [14].
Critical voices pointed to several ethical issues such as the
rise of economically motivated decisions leading to patient
harm, the rising pressure on physicians, and an increas-
ing administrative work load that might be prioritised over
the contact with patients [15]. Some anticipated a climate
of growing mistrust and feared a reduction of physicians’
autonomy [16]. Many of these concerns also applied to
nursing, including an anticipated lack of human resources
as one of the prominent worries [17]. At the same time
the importance of scientific research on the impact of DRG
was emphasised [6].
Over the past years and in light of the upcoming imple-
mentation, the number of training seminars, conferences
and published materials to familiarise Swiss health care
workers – and future DRG controllers in particular – has
increased, focusing mainly on explaining how the system





loads/Kongress_2010/Alpiger__R.pdf). These events and
materials are usually matter-of-fact training, with a certain
publicity element to them, in many cases conveying DRGs
as a rational, modern management tool. Possible moral
conflicts typically remain unmentioned in these teaching
seminars.
Research on the effects of DRGs
Given the rapid spread of DRGs in many countries and the
anticipated and also anecdotally reported ethical problems
it is remarkable that only few scientific studies have been
or are being conducted. No country has so far developed a
comprehensive monitoring system that evaluates expected
benefits and problems, and which reflects the results from
an ethical perspective. However, taken together there is a
substantial body of literature that can guide the develop-
ment of a larger study on DRGs, and which also takes mor-
al problems into account.
The most prominent research projects from the USA were
studies that anticipated ethical tensions: A two-year Hast-
ings Center project on “Ethics and DRG” carried out in
the late 1980s assumed that the cost containment strategy
would leave no sector or participant in the health care sys-
tem untouched [18]. For example, the impact on nurses and
social work [19], or on the doctor-patient-relationship and
the transformation of ethical practice [20] were discussed.
Some feared drastic human cost: “If our concerns are valid,
the human cost will be unconscionable. Access, quality of
care, medical progress and the autonomy of hospitals will
all be sacrificed in the name of efficiency.” [21]. No sys-
tematic evaluation of the ethical concerns that were raised
in these early papers has been conducted.
Germany has legal requirements for a systematic scientific
evaluation of the implementation of DRGs, but this has
so far not been fully implemented (Krankenhausfinanzier-
ungsgesetz § 17 b Abs. 8). The IGES institute in Germany
is responsible for monitoring the effects of DRGs. So far,
a decrease in health care quality has not been reported. Yet
publications state that it is too early to make a final state-
ment on the effects of DRG; an explicit mention of eth-
ical aspects is missing (IGES Institut, 2010. G-DRG-Beg-
leitforschung gemäss § 17b Abs. 8 KHG. Endbericht des
ersten Forschungszyklus (2004-2006), Berlin and IGES In-
stitut, 2011. G-DRG-Begleitforschung gemäss § 17b Abs.
8 KHG. Endbericht des zweiten Forschungszyklus
(2006–2008), Berlin).
However, some isolated studies are helpful for identifying
ethically relevant criteria when implementing DRGs.
These studies are concerned with (1.) quality of health care
[22–24], (2.) working conditions of health care workers
[24–27] and (3.) access to health care [28–30].
We structured the ethical concerns which we could find in
our extensive literature research and compiled them in one
document. In order to refine and confirm the relevance of
these ethical issues for the Swiss context we sent the doc-
ument in a small Delphi Study to 67 Swiss experts from
medicine, nursing, hospital management, politics, health
insurances, advocacy groups for patients and disabled
people, medical ethics and SwissDRG AG. In a process of
written and oral exchange with the experts we developed
a detailed plan by grouping the identified areas of concern
into three clusters.
1. Patient care and relatives, including criteria such as
access to health care, coding effects on treatment and
out-patient care.
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2. Professional ethos, asking for example whether there
are conflicts of interest between the professional ethos
and the actual working conditions and if yes, what
consequences they might have.
3. The institutional and societal conditions were
considered as the context within which issues related
to patients and professionals should be situated, and
also which have to be addressed when discussing
DRGs. The result of this study was our first step for a
specific ethical evaluation of DRGs in Switzerland [1].
In general, one frequently mentioned major problem re-
lated to research on DRGs is the lack of data prior to the
introduction of DRGs. This means that an objective com-
parison before and after implementation is almost impos-
sible (it is questionable whether this is ever possible due
to complex processes parallel to the introduction of DRGs,
which also affect the health care system and the health
care workers). We could not gather comprehensive data
long before the first versions of DRGs were introduced in
Switzerland. However, we did conduct 30 qualitative inter-
views at three different hospitals in Switzerland in 2008/
2009 in which we asked questions about ideal profession-
al values and competences, the possibility to pursue them
under the actual working conditions and the influence of
economic considerations on daily work (see for example:
http://www.research-projects.uzh.ch/p15580.htm. The
publication of the analysis of the 30 interviews is currently
in preparation). Furthermore, our IDoC-project started on
1.1.2011, thus some data were collected prior to the Swiss-
wide implementation on 1.1.2012. In contrast to many oth-
er countries with experience of DRGs, the early start of our
research will provide at least some information of the situ-
ation before introduction.
Developing an ethical framework for
research on DRGs in Switzerland
Our preparatory studies, and especially the Delphi study,
were important for compiling a comprehensive list of eth-
ically relevant aspects in the Swiss context. However, it
is insufficient to merely identify ethically relevant aspects
without developing a road map of how to actually perform
research on the specific issues. In a secondary step we
therefore developed a framework within which we in-
cluded all the relevant aspects. Our current aim is that this
framework captures the issues arising in the concrete Swiss
context. Our long-term aim is to develop a more general
framework, which can also be used in different countries
and for different cost containment systems (currently we
are conducting a satellite project on case-based payment
in China which is also based on this research framework:
http://www.research-projects.uzh.ch/p15523.htm). In the
following section, we will introduce the framework for an
ethical evaluation of DRGs in Switzerland, based upon a
systematic synopsis of all aspects identified so far.
DRGs are a management tool which aim at all levels of
a health care system. At the macro level it is intended
to serve the economic viability of the health care system
through the efficient delivery of health care, cost-transpar-
ency and competition between hospitals. At the same time,
the quality of health care should not decrease for certain
subpopulations or even the entire population.
The implementation of the tool can only be enabled
through cooperation on the meso-level: Hospital manage-
ment has to ensure that DRGs are being put into place prop-
erly.
Finally, DRGs have an effect on the micro-level: health
care workers can be directly and easily motivated or even
coerced to work more efficiently. In addition, most health
care workers are likely to experience an increase in admin-
istrative workload.
With its influence on all three levels of health care, DRGs
can thus be examined from different ethical perspectives:
public health ethics, organisational ethics, and clinical or
nursing ethics. Such an ethical reflection on DRGs is chal-
lenging: The main task is to discuss specific ethical values
and possible conflicts from a certain perspective without
losing sight of the bigger picture. Ethical research should
thus contribute to a comprehensive ethical assessment of
DRGs on each specific level in relation to the other levels.
In order to achieve this, ethical research has to describe
the possible ethical conflicts on each of the above-men-
tioned levels (macro, meso and micro). Such descriptive,
empirical research is in itself a complex task and requires
the cooperative commitment of more than one discipline.
Possible questions from a descriptive view could be “Who
are vulnerable subpopulations that need special attention?”
(macro), or “Are institutional timeframes set in a way that
caring relationships can be built and that medically neces-
sary interventions can be performed?” (meso), or “What
ideas of good patient care do physicians/nurses embrace re-
garding quality of care, and do DRGs lead them into con-
flict with their professional ideals?” (micro).
Ethical research has another normative element: it must
identify the ethical assumptions that are being made within
empirical ethical research and it must evaluate the gathered
empirical data in light of ethical values. Which are the eth-
ical values at stake and why? Normative questions could
be for example “What trade-offs between cost-efficiency,
quality and fairness are acceptable in the Swiss health care
system?” (macro), or “How can fairness in hospital man-
agement best be defined?” (meso), or “What role should
health care professionals play in cost containment?” (mi-
cro).
Finally, ethical research on DRGs has a methodological
component: Given the complexity of the research topic,
ethical research has to keep a keen eye on the methods in-
volved: How should all experts involved work together and
how can the research contribute to the ethically relevant
questions? How can research deal with the problem that the
effects of DRGs can often not be isolated? Methodologic-
al questions are for example: “How can effects on access
to health care be measured?” (macro), or “Can ethically
relevant tools be implemented in routine quality monitor-
ing in hospitals?” (meso), or “Can significant evidence in a
diverse and heterogeneous field such as in-patient care be
reached?” (micro).
Currently five IDoC research subgroups are conducting re-
search on specific questions contained in this framework
(funding by the Swiss National Science Foundation is se-
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Table 1: Framework for ethical research on DRGs with exemplary questions.
Descriptive Normative Methodological
Macro level
(Health care system, population
effects)
Who are vulnerable subpopulations that
need special attention?
What trade-offs between cost-efficiency,
quality and fairness are acceptable in the
Swiss health care system?




Are institutional timeframes set in a way
that caring relationships can be built and
that medically necessary interventions
can be performed?
How can fairness in hospital
management best be defined?
Can ethically relevant tools be
implemented in routine quality monitoring
in hospitals?
Micro level
(Clinical encounter of patient with
health care worker)
What ideas of good patient care do
physicians/nurses embrace regarding
quality of care, and do DRGs lead them
into conflict with their professional
ideals?
What role should health care
professionals play in cost containment?
Can significant evidence in a diverse and
heterogeneous field such as in-patient
care be reached?
cured for a period of three years: http://p3.snf.ch/Pro-
ject-132786 and http://www.ethik.uzh.ch/ibme/forschung/
drg.html). The project focuses on three themes: (1.) quality
of health care (including patient safety), (2.) access to
health care and (3.) job satisfaction of nurses and physi-
cians (including also the perceived autonomy at work and
the compatibility of working conditions with health care
workers’ codes of ethics).
We are in the process of adjusting our overall ethical frame
and further refining the ethically relevant research ques-
tions. This complex type of research is only feasible if dif-
ferent disciplines work hand in hand. Our project therefore
includes teams from different disciplines (Medical Ethics,
Law, Nursing Science, Health Services Research. Subpro-
ject leaders are Nikola Biller-Andorno, Bernard Burnand,
Bernice Elger, Thomas Gächter, Dragana Radovanovic,
Rebecca Spirig, John-Paul Vader and Verina Wild from
the Swiss Universities of Basel, Geneva, Lausanne and
Zurich). The groups are using different methodological
tools, such as qualitative interviews, quantitative surveys,
or analysis of health care monitoring instruments. Regular
meetings and workshops are organised in order to achieve
the best cooperation and synergies possible between the
subgroups, external experts and stakeholders. As a result
we hope to produce some answers to questions raised in the
light of DRGs. We also aim to produce easy to use research
tools that manage to condense a complex matter to the most
urgent and necessary issues and that can be adapted and im-
plemented in future evaluations of cost containment instru-
ments.
Conclusion
Ethical research on DRGs is certainly not a trivial endeav-
our, and many questions might remain unanswered, but it
is worthwhile. Economic viability will be one of the main
future challenges for any health care system in the world –
and at the same time the provision of good medical care for
individual patients will remain at the heart of medicine and
nursing. The introduction of DRGs may have profound,
ethically relevant effects on health care at a macro-, meso-
and microlevel of a health care system. A systematic eth-
ical evaluation that meets the requirements outlined in this
paper is thus necessary. In this way, ethical research will
contribute to the fundamental questions, including what the
overall aims of a health care system are, how it can work
in light of rising costs in health care, what “good” health
care should consist of and what is at stake. These questions
are essential for the future development of health care sys-
tems and ultimately affect every person. Ethical research
on DRGs should therefore not be understood as a “nice-
to-have” or “add-on”, which might or might not be con-
sidered; instead it is a complex, essential element for the
evaluation of the introduction of cost containment instru-
ments.
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